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Background: Electrocardiographic (ECG) and ﬂuoroscopic criteria, which are the only avail-
able guides to achieve a true septal position during right ventricular outﬂow tract (RVOT)
pacing, have been infrequently validated. We sought to validate these using cardiac com-
puted tomographic angiography (CTA) to conﬁrm lead position within the RVOT septum.
Methods: Forty-four patients with permanent pacemaker leads in the RVOT position under-
went CTA. Lead positions in RVOT were classiﬁed as anterior, free wall, or septal location.
Fluoroscopic images were obtained in 4 standard views.
Results: Only 19 (43%) patients had lead in true septal position within the RVOT in CTA while
25 patients (57%) were found to have an anterior lead location. Mean QRS axis, QRS duration,
negative QRS in lead I, and notching in inferior leads were not signiﬁcantly different between
the two groups. The standard ﬂuoroscopic LAO view showed a rightward-directed lead not
only in all 19 patients with septal location, but also in 14/25 patients in the anterior location
(p = 0.22), and thus had a sensitivity of 100% but speciﬁcity of only 16% in predicting true
septal position. The posteriorly directed lead in left lateral view was more accurate in
predicting true septal position with good sensitivity (73.7%) and excellent speciﬁcity (80%).
Conclusions: This study, using validation with CTA, showed that conventional ECG criteria
and ﬂuoroscopy are inaccurate in differentiating septal from anterior RVOT pacing. The
ﬂuoroscopic lateral view, as corroborated by CTA, is more reliable than the LAO view in
predicting septal lead placement.
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The right ventricular apex (RVA) has been the traditional site
for ventricular pacing for more than half a century, due to the
relative ease of implantation, reliability, and stability. Howev-
er, RVA pacing is fraught with the long-term risk of left
ventricular (LV) dysfunction, heart failure, and arrhythmias,
like atrial ﬁbrillation. This led to active interest in developing
alternative sites of RV pacing, which could lead to a more
physiological pattern of ventricular activation.1–3 Sites that
have been studied are the low interventricular septum, mid-
septum, HIS bundle,1 and the RV outﬂow tract (RVOT).2 Among
these, RVOT pacing has gathered maximum interest due to its
possible favorable hemodynamic and electrophysiological
proﬁles, as compared to RVA pacing. RVOT pacing has been
shown to result in narrower QRS complexes, lesser dyssyn-
chrony, and better LV systolic function, as compared to RVA
pacing.2,3 Within the RVOT, it is the true septal position that is
most desirable.4 Acquiring a true septal location during
pacemaker implantation is technically challenging, as ﬂuo-
roscopy and occasionally electrocardiography (ECG) are
usually the only guides available to achieve true septal pacing
within the RVOT. These criteria, however, have not been
widely validated against a true anatomic 'gold standard'.
Cardiac computed tomographic angiography (CTA) is a
technique that allows complete objective assessment of the
entire geometry of the RV, including the apex and the inﬂow
and outﬂow tracts.5 We sought to validate the accuracy of ECG
and ﬂuoroscopic criteria with accurate anatomic imaging,
using cardiac CTA to conﬁrm lead position within the RVOT.
2. Methods
2.1. Patient population
Forty-four patients, who underwent permanent pacemaker
implantation in the RVOT position in the Department of
Cardiology at our institute, were enrolled in the study. Patients
were subjected to standard 12-lead ECGs, ﬂuoroscopy, and
cardiac CT angiography for localization of lead tip position in
the RVOT. All patients gave informed consent to participate in
the study, which was approved by the Institutional Ethics
Committee.
2.2. Technique of lead implantation in RVOT
Standard 58- or 60-cm bipolar active ﬁxation leads with
steroid-eluting electrodes were used for all implants. The
single, senior operator self-shaped ventricular lead stylet to
facilitate successful lead deployment onto the RVOT septum
and carried out the entire procedure of pacemaker implanta-
tion. For the purpose of lead placement, RVOT was divided as
deﬁned by Mond et al.3 into three regions: the septum, which
lays posteriorly, the free wall in front, and between them, the
narrow anterior wall of the RVOT.6 Successful lead positioning
was conﬁrmed by the three ﬂuoroscopic views: posteroanter-
ior (PA), 40 right-anterior-oblique (RAO), and 40 left-anterior-
oblique (LAO). During RVOT lead implantation, the PA viewwas used to position the lead in the midsection or outﬂow
tract. The 408 RAO is then used to conﬁrm that the lead is not in
the coronary sinus or great cardiac vein. The 408 LAO was used
to distinguish the three areas within these locations. In this
view, free wall positioning places the lead tip anteriorly (or
leftward), septal positioning places the lead posteriorly (or
rightward), and anterior wall positioning places the lead
pointing superiorly. The multiple ﬂuoroscopic views were
used to ensure correct lead placement. Target site was mid-
septum or high septum in PA view and rightward facing lead in
LAO view, but in patients where this target could not be
achieved, because of difﬁculty to obtain stable position or
failure to obtain good thresholds and sensitivity parameters, a
less than optimal position was accepted.
2.3. Electrocardiography
Twelve-lead ECGs were obtained in all patients, acquired both
at baseline, and during forced paced (at 100 beats per minute)
QRS complexes. ECGs were analyzed for several parameters
including QRS axis, QRS duration, amplitudes of all limb leads,
limb lead polarity, and presence or absence of notching in limb
leads.
2.4. Fluoroscopy
Fluoroscopic images were acquired in four standard views
postprocedure i.e. PA, LAO-408, RAO-408, and left lateral (LL)
views.
Fluoroscopic images were analyzed for conﬁrmation of lead
position in RVOT using PA and RAO views. The LAO and LL
views were analyzed for position within the RVOT. The lead tip
was designated as having either a leftward, rightward, or
superior orientation in the LAO view, and an anterior, posterior
or superior orientation in the LL view. Two senior radiologists
and a cardiologist independently analyzed the ﬂuoroscopic
images and together they decided the ﬁnal ﬂuoroscopic lead
position by consensus.
2.5. CT angiography
Cardiac CTA (64-slice Dual Source Siemens Deﬁnition) was
performed in all 44 patients to delineate the position of the
pacemaker lead tip in the RVOT. CT scans were analyzed in
axial sections perpendicular to the long axis of the RVOT, and
multiple orthogonal views to conﬁrm lead tip position in the
RVOT. Lead tip locations were designated as anterior, free wall,
or septal in location (Fig. 1). Two radiologists who were blinded
to the ﬂuoroscopic ﬁndings of the patients analyzed the CTA
for ﬁnal lead position. All patients underwent routine
interrogation of the pacemaker after the CTA.
2.6. Statistical analysis
Statistical analyses were performed using SPSS software (SPSS,
Inc., Chicago, IL, USA).
Continuous data were analyzed using paired Student's
t-test. Fisher's exact test was used for evaluating dichotomous
variables. Continuous values are expressed as mean  SD.
A p-value of <0.05 was considered statistically signiﬁcant.
Table 2 – ECG characteristics.
CT-proven
anterior
RVOT lead
(n = 25)
CT-proven
septal RVOT
lead
(n = 19)
p-value
QRS axis (8) 71  5 74  4 0.20
QRS duration (ms) 148  21 143  18 0.38
Negative QRS in lead I (n) 15 (60%) 14 (74%) 0.52
Limb lead notching (n)
 Lead I 19 (76%) 11 (58%) 0.56
 Lead II 13 (52%) 11(58%) 0.45
 Lead III 13 (52%) 10 (53%) 0.45
 Lead aVL 16 (64%) 8 (42%) 0.54
 Lead aVF 12 (48%) 12 (63%) 0.61
CT, cardiac tomography; RVOT, right ventricular outﬂow tract.
Fig. 1 – Axial section of cardiac computed tomographic
image showing the septum, anterior, and the lateral wall in
right ventricular outflow tract (RVOT).
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Forty-four patients were enrolled in the study, with a mean age
of 58  13 years. There were 33 males (74%). Thirty-one
patients (70%) had a dual-chamber pacemaker, while the rest
had single-chamber pacemakers. Complete heart block was
the most common indication for receiving a pacemaker in the
study (84%), while 4 patients (9%) had sick sinus syndrome
(Table 1). Out of 44 patients undergoing permanent pacemaker
implantation, CT angiography delineated 19 (43%) patients to
have lead tip in the septal portion of RVOT and twenty-ﬁve
(57%) patients in the anterior RVOT. No patient had a lead
lodged in the RVOT free wall. Mean distance of the lead tip
from the pulmonary valve was 2.07  0.83 cm in the anterior
group, and 2.15  0.57 cm in the septal RVOT group (p = 0.77).
3.1. Electrocardiography
Mean QRS duration of the patients with CT-proven septal
RVOT lead position was narrower in septal group as compared
to anterior group; however, it did not reach statistical
signiﬁcance (143  18 ms vs 148  21 ms, p = 0.38). QRS axis
did not differ signiﬁcantly between both groups (71  58 vs.
74  48; anterior vs. septal; p = 0.20). QRS in lead I was negative
in 14 patients (74%) in the septal group, and also in 15 patientsTable 1 – Baseline characteristics of the study population.
All patients (n = 44)
Age (years) 58  13
Male/female (n) 33/11
Dual/Single chamber (n) 31/13
Indication for pacemaker (n, %)
 Complete heart block 36 (82%)
 Sick sinus syndrome 4 (9%)
 Others 4 (9%)(60%) amongst the anterior RVOT group (p = 0.52). Thus QRS
negativity in lead I could not differentiate a septal versus
anterior lead position. There was no signiﬁcant difference with
respect to notching in any of the limb leads, including inferior
leads, comparing the two groups (Table 2).
3.2. Fluoroscopy
All patients showed appropriately placed RVOT position of the
pacemaker lead in the PA and RAO ﬂuoroscopic projections. In
LAO view, the lead was oriented rightwards in 40/44 (91%)
patients. Anatomic imaging by CT, however, revealed that only
19 out of these 40 patients indeed had a 'true' septal lead
placement, while the lead was directed anteriorly in rest 21
patients, and thus LAO had very low speciﬁcity in predicting
septal position (speciﬁcity = 16%, Table 3). However, all
patients with a CT-proven septal lead position had a rightward
facing lead in the LAO view making it 100% sensitive in
predicting septal lead position. Among the 19 patients with a
septal lead position, 14 patients had a posteriorly directed lead
and 5 were directed superiorly in the LL view (p = 0.001).
Among the 25 patients with an anterior lead position as judged
by CT angiography, 11 had an anteriorly facing lead on
ﬂuoroscopy in the LL view, while 9 had a superiorly oriented
lead, and only 5 were directed posteriorly (Table 3). Thus, a
posteriorly direction of lead in LL view had good sensitivity
(73.7%) and excellent speciﬁcity (80%) and positive predictive
value (73.7%) in predicting septal lead position (Table 3).
4. Discussion
In this study, we systematically evaluated the role of
ﬂuoroscopic imaging and paced QRS morphology in determin-
ing segmental location of pacing lead in the RVOT, as validated
by CTA. Differentiation between septal and anterior/free wall
location has traditionally been based on ﬂuoroscopic land-
marks and paced QRS morphology. Proper validation of ﬁnal
lead position using these guides, compared to an adequate
'gold standard', has never been conclusively performed. A
recent study by Pang et al.16 has also validated the ﬂuoroscopic
lead positioning with CT. They have also found a very low
percentage (21%) of true septal position with traditional
ﬂuoroguidance and have gone on to suggest a protocol based
Table 3 – Fluoroscopic characteristics of patients with sensitivity, specificity, PPV, and NPV for rightward orientation of lead
in LAO and posterior orientation of lead in LL view.
CT-proven septal
RVOT lead (n = 19)
CT-proven anterior
RVOT lead (n = 25)
p value
LAO view (n)
 Rightward orientation 19 21 0.12 Sensitivity = 19/19 = 100%
Speciﬁcity = 4/25 = 16%
PPV = 19/40 = 47.5%
NPV = 4/4 = 100%
 Not rightward orientation 0 4
Left lateral view (n)
 Posterior orientation 14 5 0.001 Sensitivity = 14/19 = 73.7%
Speciﬁcity = 20/25 = 80%
PPV = 14/19 = 73.7%
NPV = 25 = 80%
 Superior orientation 5 9
 Anterior orientation 0 11
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studies have used transthoracic echocardiography and elec-
tro-anatomical mapping as modalities for validating lead
position. CTA provides accurate delineation of RV geometry
and RVOT,5 and hence would be a gold standard in localization
of lead position in RVOT.
4.1. ECG criteria
Several ECG criteria have been proposed as indicative of septal
pacing. Mond et al. described that a negative or isoelectric-
paced QRS complex in lead I is diagnostic of a septal position,
whereas free wall position would show a positive QRS in lead
I.2 Also, anterior RVOT pacing results in a broader QRS duration
and would show notching in the inferior leads, particularly
lead III.2 These criteria, however, have been disputed.
Burri et al.7 recently studied ECG characteristics of pacingFig. 2 – Figure showing inadequacy of QRS negativity in lead I (arr
lead I while CTA (B) in the same patient confirmed the lead pos
while CTA (D) confirmed lead to be in septal location.from mid-septum and anterior free wall using electroanato-
mical mapping with a NavX system. The authors found that a
negative QRS in lead I was more frequent with anterior than
with mid-septal pacing. Interestingly, notching of QRS in
inferior leads and lead I was more common in mid-septal
pacing compared to anterior wall pacing sites. Similarly, few
studies using electroanatomical mapping8,9 found that a
negative QRS in lead I was common in both anterior septal
and free wall sites.
In our study, using accurate anatomical localization, we
demonstrated that 74% of patients with leads in the septal
position, as delineated by CT, had a negative QRS in lead I.
However, 60% of patients in the anterior RVOT group too
showed negativity in lead I (p = 0.52), demonstrating the
inadequacy of QRS negativity in lead I for septal localization
(Fig. 2). Moreover, we found no difference in the presence of
QRS notching in any of the limb leads, including inferior leads.ow label) for septal localization. (A) ECG with negative QRS in
ition to be anterior; (C) ECG showing positive QRS in lead I
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show that marked heterogeneity exists in the ECG character-
istics of pacing from a septal site, and that the conventional
ECG criteria, including lead I negativity and inferior leads
notching, are inaccurate in reliably predicting septal location
of an RVOT lead.
4.2. Fluoroscopic criteria
Fluoroscopy remains the conventional guide for accurate lead
placement during pacemaker implantation. The standard PA
and 408-RAO views help in positioning within the RVOT. For
further differentiation between the septal and free wall
aspects of the RVOT, the 408-LAO view has been proposed to
be useful, where septal positioning is characterized by a
rightward orientation of the lead tip, whereas free wall
positioning is seen with the lead tip facing leftward or
anteriorly.10,11
In addition to standard PA, LAO, and RAO views, LL was
done during postprocedure ﬂuoroscopy to conﬁrm the lead
position. In the LL view, a posteriorly directed lead indicates a
septal location, whereas a free wall/anterior lead would be
directed anteriorly or superiorly.
In our study, we found that the rightward orientation of
lead in standard LAO had 100% sensitivity and negative
predictive value in predicting septal lead position but a very
low speciﬁcity of 16% (Table 3). This clearly highlights the
inadequacy of the LAO view alone, which is conventionally the
operator's view, to reliably and correctly predict septal location
within the RVOT. On the other hand, although the LL had lower
sensitivity, it had excellent speciﬁcity and positive predictive
value. This is in keeping with conventional ﬂuoroscopic
criteria for septal localization from earlier studies.10,11 Thus
using LL view at least once during the procedure will greatly
increase the success of true septal lead placement. Sometimes
during device implantation, it is challenging to get the LL
position, and in that case, a steep LAO might be useful. A
recent study by Pang et al. has also highlighted these facts
about the inadequacy of standard ﬂuoroscopic views like LAO
and RAO alone, in guiding to a true septal lead position.16 They
have suggested a new protocol in which they propose that the
lead is more likely to be in true septum if it lies in the middle ofFig. 3 – Figure showing agreement between LAO (3A), LL (2C), an
showing rightward oriented lead in RVOT; (B) CTA showing lead
directed posteriorly.the cardiac silhouette in the RAO long-axis projection and has
an angle of 40–608 in LAO view with the angle being between a
line drawn parallel to the lead tip and a horizontal line drawn
in LAO view.16 Few studies, using 2D and 3D echocardiographic
validation, have shown a similar disagreement between the
ﬂuoroscopic criteria and actual lead position on echocardiog-
raphy.2,3,7,12 The reason as to why this discrepancy occurs in
the predictive accuracy of ﬂuoroscopic views is because the
anterior RVOT actually shares a leftward alignment along with
the septal wall, whereby a rightward facing lead on the LAO
could have an equal chance of either being on the anterior or
on the septal wall (Figs. 3 and 4). Furthermore, there is
variation in the individual patients' RVOT size, anatomy
relative orientation of the anterior and septal RVOT walls, and
rotation of heart. The RVOT curves posteriorly as we ascend
toward pulmonary valve, making it difﬁcult for exact septal
lead placement in RVOT, and one may have to settle for an
alternate location. Interestingly the septal leads were more
toward the anterior aspect of the true septum, which could be
due to more stability at this position (Fig. 3B). Also, none of the
cases had their leads on the free wall of the RVOT on CT
imaging. This could be because of the fact that the current
ﬂuoroscopy criteria are good enough to differentiate free wall
from anterior/septal location but not good enough to differen-
tiate septal from anterior location in RVOT. Also, the use of
either manually preshaped or commercially available stylets
with a distal posterior angulation in all the cases has improved
the technique of RVOT lead placement.
Acquiring a true septal location is a technically challenging
task. We feel that the use of stiffer stylets, generous distal
posterior angulation of the stylet, and use of the lateral view
(or as-steep-as possible LAO) will help in guiding the operator
toward accurate septal placement.
4.3. Implications of the study
Most important ﬁnding of this study is that the use of the
lateral view (or as-steep-as possible LAO) in addition to LAO
may increase the accuracy and success of septal lead
implantation. Findings of this study would also help explain
why studies comparing RVOT vs RV apical pacing have
generally failed to show signiﬁcant difference.13,14 Nearly alld CTA image (3B) in RVOT septal pacing site. (A) LAO view
 (arrow tip) in RVOT septum; (C) LL view showing lead
Fig. 4 – Figure showing poor correlation between LAO and CTA for lead positioning in RVOT septum. (A) LAO showing
ventricular lead oriented rightward while CTA (B) confirmed that lead (arrow) to be in RVOT-anterior wall.
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without comparison to RVA pacing have used ﬂuoroscopic
landmarks for validation of septal position. In fact, even
ongoing randomized trials that are studying the effects of RV
septal pacing compared to RVA pacing have used, in their
study design, only the LAO view as the landmark for septal
placement.15 This would imply that the many patients with
lead not in true RVOT septum will be included and that the
database of patients with so-called RV septal pacing, in fact,
does not necessarily consist wholly of only 'true' septal pacing.
5. Limitations
It is a single-center small study. Although, on the basis of the
results of this study, LL view was found to be a better predictor
of RVOT septal lead placement; we used it only after the lead
implantation because it is practically challenging to obtain this
view while maintaining strict asepsis.
6. Conclusions
Accurate localization of lead position using CT angiography
revealed that the conventional ECG criteria and standard LAO
view in ﬂuoroscopy are inaccurate in differentiating septal
from anterior RVOT pacing. The lateral view, as corroborated
by CTA, is more reliable than the LAO view in conﬁrming septal
placement.
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